Orphazymes kursridt, Sanofi opgiver diabetesmarkedet og Leo Pharma rammer plet med fremtidshåb
Dec 13, 2019 ·
11m 33s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
MedWatch-redaktionen taler om biotekselskabet Orphazyme, Sanofis exit fra diabetesmarkedet og Leo Pharmas nye studieresultater, der giver håb om at kunne konkurrere med blockbustermidlet Dupixent.
Information
| Author | Watch Medier |
| Organization | Watch Medier |
| Website | - |
| Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
